Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Metabolically-inactive glucagon-like peptide-1(9–36)amide confers selective protective actions against post-myocardial infarction remodelling

Fig. 2

Effect of GLP-1(9–36) on cardiac function post-MI. a LV end-diastolic volume (LVEDV), b LV end-systolic volume (LVESV), c LV ejection fraction, d LV fractional shortening, e mitral valve E/A ratio, and f E wave deceleration rate, assessed by echocardiography (n = 8–19). White columns, sham; black columns, MI mean ± SEM. ***P < 0.001 versus corresponding sham. †††P < 0.001 versus corresponding MI

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840